fda warning letters compounded semaglutide tirzepatide 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Thinking about buying GLP-1 and

Some providers attempt to navigate this by prescribing Ozempic off-label for weight loss in patients with prediabetes or metabolic syndrome

Tirzepatide generally produces greater average weight loss than semaglutide in clinical studies

Incorporating nutrient-dense foods and maintaining an active lifestyle are critical components of long-term success

Concurrently, its localization in the mucus layer raises inquiries regarding long-term effects on mucosal integrity in various host contexts ( Additionally, large-scale manufacturing necessitates strict anaerobic processes and meticulous control of batch-to-batch consistency (402)